Atrial natriuretic peptide: synthesis, release, and metabolism.
about
Atrial natriuretic peptide infusion and nitric oxide inhalation in patients with acute respiratory distress syndromeCardiac fibrosis in myocardial infarction-from repair and remodeling to regenerationContribution of pressure natriuresis to control of total body sodium: balance studies in freely moving dogsAtrial natriuretic peptide and oxytocin induce natriuresis by release of cGMPMaturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissuesHypoxia exposure and B-type natriuretic peptide release from Langendorff heart of rats.The mixed-lineage kinase 1-3 signalling pathway regulates stress response in cardiac myocytes via GATA-4 and AP-1 transcription factorsEvidence for cross-talk between atrial natriuretic peptide and nitric oxide receptorsDifferential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.(Pro)renin receptor triggers distinct angiotensin II-independent extracellular matrix remodeling and deterioration of cardiac function.A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.Vasopeptidase inhibitors: will they have a role in clinical practice?The Early-Onset Myocardial Infarction Associated PHACTR1 Gene Regulates Skeletal and Cardiac Alpha-Actin Gene Expression.Heterogeneous nuclear ribonucleoprotein A1 is a novel cellular target of atrial natriuretic peptide signaling in renal epithelial cells.Natriuretic peptide metabolism, clearance and degradation.Renal effects of TAPP, a highly selective mu-opioid agonistGuanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.Glucose transporter (GLUT-4) is targeted to secretory granules in rat atrial cardiomyocytesEarly decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patientsNovel analog of atrial natriuretic peptide selective for receptor-A produces increased diuresis and natriuresis in rats.A constitutively "phosphorylated" guanylyl cyclase-linked atrial natriuretic peptide receptor mutant is resistant to desensitizationDiastolic dysfunction: a link between hypertension and heart failure.Secretory granule targeting of atrial natriuretic peptide correlates with its calcium-mediated aggregation.The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.Oxytocin: Old Hormone, New Drug.Characterization of natriuretic peptide receptor subtypes in the AtT-20 pituitary tumour cell lineRole of prostaglandin-mediated cyclic AMP formation in protein kinase C-dependent secretion of atrial natriuretic peptide in rat cardiomyocytesEffect of endopeptidase-24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat.Humoral control of airway tone.ANP expression in the hypertensive heart.Cardiac atria are the primary source of ANP release in hypoxia-adapted rats.Effect of endopeptidase-24.11 inhibitors and C-ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide.Temperature has a major influence on cardiac natriuretic peptide in salmon.Stretch-activated and background non-selective cation channels in rat atrial myocytes.
P2860
Q24798057-959F9C0B-889C-494E-86BC-EE4D4BA9108CQ28068468-C987BC1E-BD05-4231-A161-E85415442D80Q28366529-7E47BB5B-8E48-432A-927A-2DEB46C98C6BQ28369486-94CD8249-9887-4E51-A9AF-1A03743E5197Q28550738-B4F58E1B-56C6-4CC5-B276-18622334F4B9Q33625970-A91EDD06-1CAD-4444-BF2D-C635F9988F4EQ33685976-44C36EEA-4240-4145-8DB5-3654902B1D17Q33824523-7EF3E0EC-3DB1-4AE0-A98C-736C3F43C0C0Q33909668-5687A618-A674-4403-AEC5-C45D20F584A3Q34387893-8FC6821E-A542-4F69-A84D-DC0333A98942Q34486162-3864C1E4-AF9C-4BEF-9CC8-3D513E1AFC38Q35608907-2202F9D8-162F-49B9-95A3-6FE83F1D6C75Q35670345-2B0C7599-0E15-49B7-9EBD-28AD125ED13FQ35783161-610C390F-3DA8-4F33-89BC-0C7BFD8E68ACQ35831469-B140C2C8-A62F-4DE0-BC51-37B9EB9EA382Q35884692-CBAB6DA2-C3DC-4FD4-AFB6-87F698EB2940Q35936915-B7FADE63-BDDF-4F3A-8E33-3F541369FECEQ36254738-9117B9A2-0E5D-4ED0-B6D2-BB4026CDAC0CQ36644505-2785FD8F-C25F-4142-88A6-CF2F26C31CBEQ36815309-7EF12C79-2A24-4827-9FE5-6C5EDABFC9ABQ36879609-65B220E5-493C-4021-961C-DF9A394C00F4Q37270165-8F70D6DF-AED5-402C-B8DD-9D067374C6A9Q37353626-1449C4D9-0B83-4602-A641-1BFEFA3497D3Q37583865-E3CC13B5-BF01-453E-BA3F-6C430F31981DQ37689872-12BA5C7A-892B-411F-89D1-0C6ED28F228DQ41473766-D63EA9C7-0CE8-44B3-87B3-BF3551E81395Q41897779-DF0353E8-5445-4D39-8432-8822FADD7704Q42175281-892066E0-EC20-4C4B-84B6-7D0918136A51Q42420175-2B5D2F67-9070-4403-BEE0-16BCC6D7EC68Q42668126-D5C3272C-DF4C-484F-A8D1-569F454E60F7Q42697098-7B4F7E4B-5C01-4B17-AD46-41ECB228C982Q42706964-86541520-90A9-4CCF-A2B5-616F5F344C59Q48770326-D8F9CD3A-104F-4E4A-B84C-6BC6D22ED8B7Q53915631-591D5EA2-9FE6-44DB-9DE7-41D6CB596557
P2860
Atrial natriuretic peptide: synthesis, release, and metabolism.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Atrial natriuretic peptide: synthesis, release, and metabolism.
@ast
Atrial natriuretic peptide: synthesis, release, and metabolism.
@en
type
label
Atrial natriuretic peptide: synthesis, release, and metabolism.
@ast
Atrial natriuretic peptide: synthesis, release, and metabolism.
@en
prefLabel
Atrial natriuretic peptide: synthesis, release, and metabolism.
@ast
Atrial natriuretic peptide: synthesis, release, and metabolism.
@en
P1476
Atrial natriuretic peptide: synthesis, release, and metabolism.
@en
P2093
Ruskoaho H
P304
P577
1992-12-01T00:00:00Z